Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1180454 | 0.87 | NR1H4 (1.00) | NR1H4 | |
| SCHEMBL1179789 | 0.81 | NR1H4 (1.00) | NR1H4 | |
| SCHEMBL1180127 | 0.81 | NR1H4 (1.00) | NR1H4 | |
| SCHEMBL1180458 | 0.78 | NR1H4 (0.83) | NR1H4 | |
| SCHEMBL24212454 | 0.77 | NR1H4 (1.00) | NR1H4 | |
| SCHEMBL16456676 | 0.77 | NR1H4 (0.80) | NR1H4 | |
| SCHEMBL3644591 | 0.76 | NR1H4 (0.77) | NR1H4 | |
| SCHEMBL2000553 | 0.76 | NR1H4 (0.77) | NR1H4 | |
| SCHEMBL12871086 | 0.76 | NR1H4 (0.79) | NR1H4 | |
| SCHEMBL1179336 | 0.75 | NR1H4 (0.78) | NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110034507-A1 | FARNESOID X RECEPTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034507-A1 | FARNESOID X RECEPTOR AGONISTS | NR1H4, NR1H3, NR1H2 | NR1H4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.